Rhubarb root and rhizome-based Chinese herbal prescriptions for acute ischemic stroke: A systematic review and meta-analysis

Complementary Therapies in Medicine

Volumn 22, Issue 6, 2014, Pages 1060-1070

  Lu, Lin ^a   Li, Hui Qin ^a   Fu, Deng Lei ^a   Zheng, Guo Qing ^a   Fan, Ji Ping ^b  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Acute ischemic stroke; Chinese herbal medicine; Meta analysis; Rhubarb root and rhizome; Systematic review

Indexed keywords

HERBACEOUS AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; BARTHEL INDEX; BLOOD VISCOSITY; BRAIN ISCHEMIA; CHINESE HERB; CHINESE MEDICINE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PLANT ROOT; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHIZOME; RHUBARB; SYSTEMATIC REVIEW; CHEMISTRY; MIDDLE AGED; PHYTOTHERAPY; PROCEDURES; RHEUM; STROKE;

AGED; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT ROOTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHEUM; RHIZOME; STROKE;

EID: 84912533620     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.10.002     Document Type: Review

References (52)

1. Tsai C.F., Thomas B., Sudlow C.L. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology 2013, 81(3):264-272.
2. Jauch E.C., Saver J.L., Adams H.P., Bruno A., Connors J.J., Demaerschalk B.M., Khatri P., McMullan P.W., Qureshi A.I., Rosenfield K., Scott P.A., Summers D.R., Wang D.Z., Wintermark M., Yonas H. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44:870-947. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology.
3. Demaerschalk B.M., Yip T.R. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke 2005, 36:2500-2503.
4. Ward law J.M., Murray V., Berge E., Del Zoppo G.J. Thrombolysis for acute ischemic stroke. Cochrane Database of Systematic Reviews 2009, 4:1-40. (ID CD000213).
5. Wu B., Liu M., Liu H., Li W., Tan S., Zhang S., Fang Y. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 2007, 38:1973-1979.
6. Zhang Y., Yang J.S. Theoretical Study of Tongfu Prevention and Treatment of Stroke 2006, China Academy of Traditional Chinese Medicine, (Master's Thesis) Available at 〈http://www.dissertationtopic.net/doc/1002776〉 (assessed: Jan 25, 2014〉.
7. Wang Y.Y., Li X.Q., Deng Z.M., Sun S.L., Long C.X., Ren Z.L., Feng X.F., Wang Y.L., Zhao W., Zhang Y.L., Ren K., Zhao S.Y., Zhang L.P., Chen Z.G. Clinical observation of treating 158 cases of acute ischemic stroke by Tongfu and dispersing phlegm method. China Journal of Traditional Chinese Medicine and Pharmacy 1986, 1:22-24.
8. Liu X.Z., Wang X.Z., Yang H.Y. Discussion on the laws of medicine application when treating apoplexy by dredging Fu therapy. Journal of Beijing University of Traditional Chinese Medicine (Clinical Medicine) 2003, 10(3):45-47.
9. Wang Y.Y., Zhang Y., Zhao M.L. Study on law using Chinese herbs of Tongfu method to stroke. Chinese Journal of Basic Medicine in Traditional Chinese Medicine 2006, 12:602-604.
10. Wang Y.Y., Xie Y.Z. Origin and development of therapy of resolving phlegm and relaxing bowels for treating syndrome of phlegm heat and bowel excess of stroke (I): history, origin, syndromes, pathogenesis and clinical application. Journal of Beijing University of Traditional Chinese Medicine (Clinical Medicine) 2013, 20(1):1-6. (24).
11. Chan K., Shaw D., Simmonds M.S., Leon C.J., Xu Q., Lu A., Sutherland I., Ignatova S., Zhu Y.P., Verpoorte R., Williamson E.M., Duez P. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese Materia Medica. Journal of Ethnopharmacology 2012, 140(3):469-475.
12. Jorgensen H.S., Nakayama H., Raaschou H.O., Vive-Larsen J., Stoier M., Olsen T.S. Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study. Archives of Physical Medicine and Rehabilitation 1995, 76:406-412.
13. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta analyses: the PRISMA statement. PLoS Medicine 2009, 6:e1000097. PRISMA Group.
14. Chen Q.T. Classification, diagnostic criteria and evaluation of neurological impairment for stroke patients. Chinese Journal of Neurology 1996, 29(6):376-383. (in Chinese).
15. Rao L.M. China guidelines for cerebrovascular disease prevention and treatment. Journal of Apoplexy and Nervous Diseases 2006, 23(1):4-8. (Abstract 3, in Chinese).
16. Furlan A.D., Pennick V., Bombardier C., van Tulder M. 2009 Updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009, 34:1929-1941.
17. Yang T.B., Tan H., Peng Q.L. Clinical observation on treating 50 cases of acute cerebral infarction with Taohe chengqi decoction plus erigeron injection. Journal of Medicine & Pharmacy of Chinese Minorities 2004, 10(Suppl. 1):49-51. (in Chinese).
18. Li Q.Q. Effects of Xinglou Chengqi Decoction in treatment of 120 cases of acute stroke. Zhejiang Journal of integrated traditional Chinese and Western Medicine 2007, 17(1):31. (in Chinese).
19. Niu Y.Y. Clinical efficacy of early intervention of phlegm-heat and fu-excess syndrome in ischemic stroke with Chinese herbal medicine. Journal of Emergency in Traditional Chinese Medicine 2008, 17(7). 894, 909 (in Chinese).
20. Wang J.Q., Wang B.L., Yang W.Q. Clinical effect of modified Dachengqi decoction in treatment of 30 cases of massive cerebral infarction. Journal of Emergency in Traditional Chinese Medicine 2009, 18(3). 348, 371 (in Chinese).
21. Tan Z.H., Tu J.W., Dong M.J., Chen K.J., Zhang J.F. Clinical study on modified Chengqi decoction in treating acute cerebral infarction. Journal of Emergency in Traditional Chinese Medicine 2004, 13(5):274-275. (in Chinese).
22. Shu Y.Q., Liu T., Gan Z.R. Effect of Jiawei Xinglou Chengqi Tang on neurological function and ability of daily life as well as hemorheological indexes in patients with evil-heat sputum evidence-based acute cerebral infarction. Chinese Journal of Clinical Rehabilitation 2006, 10(15):3-5. (in Chinese).
23. Liu J.H. Observation on treating acute ischemic stroke for 28 cases with Sanhua Tang. Western Journal of Traditional Chinese Medicine 2011, 24(7):61-63. (in Chinese).
24. Yang Z.Z., Sun Y.K., Tian M.D. Clinical study on integrative medicine in treatment of 40 cases of acute cerebral infarction. Jiangsu Journal of Traditional Chinese Medicine 2009, 41(7):33-34. (in Chinese).
25. Yang X.Y., Zhang G.M. Clinical Efficacy of Xinglou Chengqi Decoction in Treatment of Acute Ischemic Stroke with Syndrome of Phlegm-heat and Fu-excess 2009, Beijing University of Chinese Medicine, (Master Thesis, in Chinese).
26. Du L., Zhu M. Clinical Observation of Compound Xinglou Chengqi Prescription Facilitating Bowel Movement on Treating Acute Cerebral Infarction May, 2008, Guangzhou University of Chinese Medicine, (Master Thesis, in Chinese).
27. Kong X.Y., Zhang S.Y. Clinical Study of Treating the Acute Cerebral Ischemic Stroke with Therapy of Dredging Qi of Fu-organ and Subsiding Reverse April, 2003, Shandong University of Chinese Medicine, (Master Thesis, in Chinese).
28. Zhang L.C., Zhang Y.L., Zhou Z., Bai H.M., Lin C.R. Clinical observation on ischemia apoplectic coma with retention enema of modified minor decoction of Dachengqi Decoction. Global Traditional Chinese Medicine 2009, 2(1):31-34. (in Chinese).
29. Ernst E., Lee M.S. A trial design that generates only "positive" results. Journal of Postgraduate Medicine 2008, 54:214-216.
30. De Angelis C., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., Kotzin S., Laine C., Marusic A., Overbeke A.J., Schroeder T.V., Sox H.C., Van Der Weyden M.B. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. New England Journal of Medicine 2004, 117:U1054. International Committee of Medical Journal Editors.
31. Kjaergard L.L., Villumsen J., Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001, 135:982-989.
32. Schulz K.F., Grimes D.A. Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005, 365:1348-1353.
33. Vickers A., Goyal N., Harland R., Rees R. Do certain countries produce only positive results?. A systematic review of controlled trials. Controlled Clinical Trials 1998, 19:159-166.
34. Dai Y.Y., Huang H.J., Wang X.T., Zheng G.Q. Effects of Sanhua decoction on expression of sodium ion channel in cerebral infarct zone in rats. Chinese Journal of Clinicians (Electronic Edition) 2011, 5(14):4079-4083. (in Chinese).
35. Zhang C.G., Zhen G.Q., Huang H.J., Wang X.T. Mechanism of Sanhua decoction on aquaporin 4 in rats with brain edema after acute cerebral ischemia/reperfusion. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2007, 14(6):352-356. (in Chinese).
36. Fan K.F., Li X.L., Liang X.D., Tang Y.X. The protective effect of Sanhua Tang on blood brain barrier injury in cerebral ischemia-reperfusion rats. Chinese Journal of Experimental Traditional Medical Formulae 2012, 18(7):181-184. (in Chinese).
37. Fan K.F., Liang X.D., Li X.L., Tang Y.X. The effect of Sanhua Tang on expression of ZO-1 in brain tissues of cerebral ischemia-reperfusion rats. Chinese Journal of Experimental Traditional Medical Formulae 2012, 18(9):216-219. (in Chinese).
38. Fan K.F., Li X.L., Liang X.D., Tang Y.X. The effect of Sanhua Tang on expression of MMP-9 in brain tissues of cerebral ischemia-reperfusion rats. Chinese Journal of Experimental Traditional Medical Formulae 2012, 18(6):210-214. (in Chinese).
39. Fan K.F., Tang Y.X., Li X.L. The effect of Sanhua decoction on neurological function, brain water content and brain morphology of cerebral ischemia-reperfusion in rats. Chinese Journal of Experimental Traditional Medical Formulae 2011, 17(24):159-162. (in Chinese).
40. Fan K.F., Li S.Y., Tang Y.X., Liang X.D. Effect of Sanhua decoction on expression of IL-1β and ICAM-1 in brain tissues of cerebral ischemia/reperfusion rats. Shandong Journal of Traditional Chinese Medicine 2011, 30(12):871-874. (in Chinese).
41. Guan M., Gong C.M., Guan X.W. Effect of Taohe Chengqi decoction on cerebral hypoxia in rats. Pharmacology and Clinics of Chinese Materia Medica 1998, 14(3):11-12. (in Chinese).
42. Liu Y., Hu J.P., Wu L. Comparative study on the influence of 3 Chinese herbal compound formulae on the expression of MPO and ICAM-1 protein in cerebral tissue after focal ischemia/reperfusion in rats. Beijing Journal Traditional Chinese Medicine 2008, 27(3):216-219. (in Chinese).
43. Hu J.P., Wang J., Wu L., Li Z.H., Yu L.H. The dynamic study on the influence of 3 Chinese herbal compound formula on the expression of ICAM-1 and NF-κB protein in cerebral tissue after focal ischemia-reperfusion in rats. Journal of Emergency in Traditional Chinese Medicine 2007, 16(5):571-573. (in Chinese).
44. Zhai C.Y., Hu J.P., Wang J., Yu L.H., Han X.X. Comparative study on effects of three traditional medical compounds on vWF and TM in plasma of rats after focal cerebral ischemia and reperfusion. Journal of Emergency in Traditional Chinese Medicine 2008, 17(10):1419-1420. (1448, in Chinese).
45. Liu J.X., Li J.S., Yu W., Hei C.C., Liu H.X., Ren F.F. Effects of Xinglou chengqi decoction and Buyang huanwu decoction on the injury of hippocampal neurons in rats with cerebral ischemia. Chinese Journal of Experimental Traditional Medical Formulae 2012, 18(12):233-237. (in Chinese).
46. Liu J.X., Li J.S., Yu W., Hei C.C., Liu H.X., Ren F.F. The effects of Xinglou chengqi decoction and Buyang huanwu decoction on Fas/Fasl and Caspase-3 pathway of apoptosis in rats with cerebral ischemia. Chinese Journal of Experimental Traditional Medical Formulae 2012, 18(23):168-172. (in Chinese).
47. Kotsirilos V. Complementary and alternative medicine. Part 2. Evidence and implications for GPs. Australian Family Physician 2005, 34:689-691.
48. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Medicine 2010, 7:e1000251. CONSORT Group.
49. Bian Z., Liu B., Moher D., Wu T., Li Y., Shang H., Cheng C. Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development. Frontiers of Medicine 2011, 5:171-177.
50. Flower A., Witt C., Liu J.P., Ulrich-Merzenich G., Yu H., Lewith G. Guidelines for randomised controlled trials investigating Chinese herbal medicine. Journal of Ethnopharmacology 2012, 140:550-554.
51. Jiang M., Lu C., Zhang C., Yang J., Tan Y., Lu A., Chan K. Syndrome differentiation in modern research of traditional Chinese medicine. Journal of Ethnopharmacology 2012, 140:634-642.
52. Wang J., Xiong X. Current situation and perspectives of clinical study in integrative medicine in china. Evidence-Based Complementary and Alternative Medicine 2012, 9:268542.